Deeter Investments’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
Other funds holding CAPR
Deeter Investments's CAPR Position: Q3 2026 in Review
Deeter Investments opened a new position in Capricor Therapeutics (CAPR) in Q3 2026: 80,898 shares worth $766K. The stake represents 0.11% of the portfolio and ranks #88 among its holdings.
158 funds tracked by Wall St. Rank hold CAPR as of Q3 2026.
- Deeter Investments held 80,898 shares of Capricor Therapeutics worth $766K as of Q3 2026.
- Capricor Therapeutics was a new Deeter Investments position in Q3 2026.
- Capricor Therapeutics made up 0.11% of Deeter Investments's portfolio in Q3 2026, its #88 holding.
- 158 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2026.
Based on Deeter Investments's 13F filing for Q3 2026, filed 16 Nov 2026.